158 related articles for article (PubMed ID: 35596148)
1. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
Larsen PT; Jørgensen SF; Njor SH
BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
[TBL] [Abstract][Full Text] [Related]
3. Subsequent participation in organized FIT based screening following screen-derived colonoscopy
Bülow Therkildsen S; Larsen PT; Njor S
Prev Med Rep; 2023 Apr; 32():102125. PubMed ID: 36816764
[TBL] [Abstract][Full Text] [Related]
4. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
[TBL] [Abstract][Full Text] [Related]
5. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
6. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract][Full Text] [Related]
8. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of colorectal cancer and use of colonoscopy before colorectal cancer diagnosis among individuals with inflammatory bowel disease: A population-based study.
Hansen TM; Nugent Z; Bernstein CN; Samadder NJ; Murthy SK; Singh H
PLoS One; 2022; 17(8):e0272158. PubMed ID: 35913956
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
12. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
13. The impact of diabetes on cancer detection during the prevalence round of a national screening program for colorectal cancer.
Graversen SB; Nannsen AØ; Bjerg L; Larsen MB; Andersen B; Laurberg T
Diabet Med; 2023 Apr; 40(4):e15043. PubMed ID: 36655559
[TBL] [Abstract][Full Text] [Related]
14. Reasons for participation and non-participation in colorectal cancer screening.
Berg-Beckhoff G; Leppin A; Nielsen JB
Public Health; 2022 Apr; 205():83-89. PubMed ID: 35248951
[TBL] [Abstract][Full Text] [Related]
15. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
[TBL] [Abstract][Full Text] [Related]
16. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
17. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
18. Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round.
Stegeman I; de Wijkerslooth TR; Mallant-Hent RC; de Groot K; Stroobants AK; Fockens P; Mundt M; Bossuyt PM; Dekker E
BMC Gastroenterol; 2012 Jun; 12():73. PubMed ID: 22713100
[TBL] [Abstract][Full Text] [Related]
19. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
20. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
